Lidocaine and magnesium sulfate in renal colic

Effectiveness of Intravenous Lidocaine, Intravenous Magnesium Sulfate and Intravenous Ketorolac for Pain Management In Patient With Renal Colic

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20090923002496N13

Enrollment

100

Registered

2023-06-21

Start date

2023-07-06

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. Urolithiasis

Interventions

Intervention 1: Intervention group: intravenous Lidocaine. Intervention 2: Intervention group: intravenous magnesium sulfate. Intervention 3: Control group: intravenous ketorolac.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with acute renal colic

Exclusion criteria

Exclusion criteria: History of kidney disease History of cardiac disease History of hepatic disease Pregnant patients History of asthma History of allergy to any of the drugs in study

Design outcomes

Primary

Measure	Time frame
Pain score in 5th, 10th, 15th and 30th minutes after drug administration. Timepoint: 5, 10, 15, 30 minutes. Method of measurement: VAS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Soleimanpour

Tabriz University of Medical Sciences

soleimanpourh@tbzmed.ac.ir+98 41 3335 2078

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026